Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Medicinova (MNOV) EBITDA Margin (2021 - 2025)

Medicinova (MNOV) has disclosed EBITDA Margin for 5 consecutive years, with 2470.94% as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA Margin changed N/A to 2470.94% in Q4 2025 year-over-year; TTM through Dec 2025 was 4943.13%, a N/A change, with the full-year FY2025 number at 2926.83%, changed N/A from a year prior.
  • EBITDA Margin was 2470.94% for Q4 2025 at Medicinova, up from 2741.67% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 4.87% in Q1 2021 to a low of 9565.76% in Q3 2021.
  • A 3-year average of 2979.58% and a median of 2470.94% in 2025 define the central range for EBITDA Margin.